Revelation Biosciences Inc (NASDAQ:REVB) has a beta value of 0.20 and has seen 69595.0 shares traded in the last trading session. The company, currently valued at $2.23M, closed the last trade at $4.28 per share which meant it gained $0.12 on the day or 2.88% during that session. The REVB stock price is -1522.43% off its 52-week high price of $69.44 and 21.96% above the 52-week low of $3.34. If we look at the company’s 10-day average daily trading volume, we find that it stood at 93920.0 shares traded. The 3-month trading volume is 229.14K shares.
The consensus among analysts is that Revelation Biosciences Inc (REVB) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -10.32.
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Sporting 2.88% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the REVB stock price touched $4.28 or saw a rise of 4.68%. Year-to-date, Revelation Biosciences Inc shares have moved -41.97%, while the 5-day performance has seen it change 4.14%. Over the past 30 days, the shares of Revelation Biosciences Inc (NASDAQ:REVB) have changed -45.41%. Short interest in the company has seen 63430.0 shares shorted with days to cover at 0.13.
Revelation Biosciences Inc (REVB) estimates and forecasts
The company’s shares have lost -70.37% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
Earnings growth for 2025 is a modest -1311.32% while over the next 5 years, the company’s earnings are expected to decrease by -23.98%.
REVB Dividends
Revelation Biosciences Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
Insiders own 0.03% of the company shares, while shares held by institutions stand at 11.80% with a share float percentage of 11.81%. Investors are also buoyed by the number of investors in a company, with Revelation Biosciences Inc having a total of 10.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund. As of Nov 30, 2024 , the former fund manager holds about 0.10% shares in the company for having 501.0 shares of worth $2144.0 while later fund manager owns 184.0 shares of worth $787.0 as of Nov 30, 2024 , which makes it owner of about 0.04% of company’s outstanding stock.
